The healthcare field is experiencing a important shift in blood sugar therapy with the arrival of GLP-1 transdermal devices. These innovative vehicles offer a likely simple choice to subcutaneous injections for individuals dealing with diabetes mellitus type 2. By circumventing the need for frequ